4CPS-217 Hepatitis b treatment: towards effectiveness and adherence

BACKGROUND: Although hepatitis B (HB) drugs have strong antiviral activity, they cannot eradicate the virus, so they must be administered for long periods of time, making long-term adherence difficult to maintain. Non-adherent patients are more likely to have virologic failure, so it is necessary to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Centeno, B Lopez, Castro, V Alonso, Martín, A Gil, Casasempere, I Martín, Oyarzábal, A Aranguren, Alcántara, MJCalvo
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535453/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.307
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares